The Ensign Group, Inc. (ENSG)
USD 136.41
(-2.56%)
USD 136.41
(-2.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.17 Billion USD | 21.02% |
| 2022 | 3.45 Billion USD | 21.1% |
| 2021 | 2.85 Billion USD | 11.98% |
| 2020 | 2.54 Billion USD | 7.78% |
| 2019 | 2.36 Billion USD | 99.83% |
| 2018 | 1.18 Billion USD | 7.21% |
| 2017 | 1.1 Billion USD | 10.13% |
| 2016 | 1 Billion USD | 33.87% |
| 2015 | 747.75 Million USD | 51.39% |
| 2014 | 493.91 Million USD | -35.04% |
| 2013 | 760.31 Million USD | 10.05% |
| 2012 | 690.86 Million USD | 15.85% |
| 2011 | 596.33 Million USD | 24.27% |
| 2010 | 479.89 Million USD | 22.63% |
| 2009 | 391.34 Million USD | 31.81% |
| 2008 | 296.9 Million USD | 11.04% |
| 2007 | 267.38 Million USD | 40.34% |
| 2006 | 190.53 Million USD | 59.59% |
| 2005 | 119.39 Million USD | 0.0% |
| 2003 | 62.53 Million USD | 93.94% |
| 2002 | 32.24 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.3 Billion USD | 3.13% |
| 2024 Q3 | 4.62 Billion USD | 4.32% |
| 2024 Q2 | 4.43 Billion USD | 2.99% |
| 2023 Q4 | 4.17 Billion USD | 2.34% |
| 2023 FY | 4.17 Billion USD | 21.02% |
| 2023 Q1 | 3.86 Billion USD | 11.88% |
| 2023 Q2 | 3.95 Billion USD | 2.33% |
| 2023 Q3 | 4.08 Billion USD | 3.28% |
| 2022 Q1 | 3.04 Billion USD | 6.8% |
| 2022 Q3 | 3.26 Billion USD | 4.5% |
| 2022 FY | 3.45 Billion USD | 21.1% |
| 2022 Q2 | 3.12 Billion USD | 2.63% |
| 2022 Q4 | 3.45 Billion USD | 5.72% |
| 2021 Q1 | 2.51 Billion USD | -1.3% |
| 2021 FY | 2.85 Billion USD | 11.98% |
| 2021 Q2 | 2.64 Billion USD | 5.42% |
| 2021 Q3 | 2.81 Billion USD | 6.22% |
| 2021 Q4 | 2.85 Billion USD | 1.32% |
| 2020 Q1 | 2.38 Billion USD | 1.1% |
| 2020 Q4 | 2.54 Billion USD | 3.27% |
| 2020 Q2 | 2.48 Billion USD | 4.19% |
| 2020 Q3 | 2.46 Billion USD | -0.93% |
| 2020 FY | 2.54 Billion USD | 7.78% |
| 2019 Q2 | 2.32 Billion USD | 4.65% |
| 2019 Q3 | 2.35 Billion USD | 1.64% |
| 2019 Q4 | 2.36 Billion USD | 0.1% |
| 2019 FY | 2.36 Billion USD | 99.83% |
| 2019 Q1 | 2.21 Billion USD | 87.69% |
| 2018 Q3 | 1.14 Billion USD | 1.57% |
| 2018 Q4 | 1.18 Billion USD | 3.36% |
| 2018 Q2 | 1.12 Billion USD | 3.03% |
| 2018 FY | 1.18 Billion USD | 7.21% |
| 2018 Q1 | 1.09 Billion USD | -0.88% |
| 2017 Q1 | 984.46 Million USD | -1.65% |
| 2017 Q4 | 1.1 Billion USD | 2.95% |
| 2017 Q3 | 1.07 Billion USD | 3.75% |
| 2017 Q2 | 1.03 Billion USD | 4.85% |
| 2017 FY | 1.1 Billion USD | 10.13% |
| 2016 Q3 | 853.41 Million USD | 1.59% |
| 2016 FY | 1 Billion USD | 33.87% |
| 2016 Q4 | 1 Billion USD | 17.3% |
| 2016 Q2 | 840.07 Million USD | 8.58% |
| 2016 Q1 | 773.68 Million USD | 3.47% |
| 2015 Q4 | 747.75 Million USD | 9.56% |
| 2015 Q3 | 682.5 Million USD | 8.52% |
| 2015 Q2 | 628.93 Million USD | 9.71% |
| 2015 Q1 | 573.29 Million USD | 16.07% |
| 2015 FY | 747.75 Million USD | 51.39% |
| 2014 FY | 493.91 Million USD | -35.04% |
| 2014 Q2 | 380.83 Million USD | -50.64% |
| 2014 Q3 | 402.87 Million USD | 5.79% |
| 2014 Q4 | 493.91 Million USD | 22.6% |
| 2014 Q1 | 771.47 Million USD | 1.47% |
| 2013 Q1 | 711.5 Million USD | 2.99% |
| 2013 Q4 | 760.31 Million USD | 2.99% |
| 2013 Q2 | 723.59 Million USD | 1.7% |
| 2013 Q3 | 738.24 Million USD | 2.02% |
| 2013 FY | 760.31 Million USD | 10.05% |
| 2012 Q3 | 667.94 Million USD | 3.25% |
| 2012 Q1 | 625.2 Million USD | 4.84% |
| 2012 Q2 | 646.92 Million USD | 3.47% |
| 2012 Q4 | 690.86 Million USD | 3.43% |
| 2012 FY | 690.86 Million USD | 15.85% |
| 2011 Q1 | 501 Million USD | 4.4% |
| 2011 FY | 596.33 Million USD | 24.27% |
| 2011 Q4 | 596.33 Million USD | 5.22% |
| 2011 Q3 | 566.78 Million USD | 11.51% |
| 2011 Q2 | 508.27 Million USD | 1.45% |
| 2010 Q2 | 410.73 Million USD | 1.94% |
| 2010 Q4 | 479.89 Million USD | 12.88% |
| 2010 Q3 | 425.13 Million USD | 3.51% |
| 2010 FY | 479.89 Million USD | 22.63% |
| 2010 Q1 | 402.9 Million USD | 2.95% |
| 2009 Q4 | 391.34 Million USD | 21.59% |
| 2009 Q3 | 321.85 Million USD | 2.28% |
| 2009 Q2 | 314.68 Million USD | 2.06% |
| 2009 FY | 391.34 Million USD | 31.81% |
| 2009 Q1 | 308.33 Million USD | 3.85% |
| 2008 Q2 | 276.03 Million USD | 2.07% |
| 2008 FY | 296.9 Million USD | 11.04% |
| 2008 Q4 | 296.9 Million USD | 5.06% |
| 2008 Q3 | 282.61 Million USD | 2.38% |
| 2008 Q1 | 270.44 Million USD | 1.14% |
| 2007 Q1 | 194.31 Million USD | 1.99% |
| 2007 Q3 | 203.4 Million USD | 3.98% |
| 2007 FY | 267.38 Million USD | 40.34% |
| 2007 Q4 | 267.38 Million USD | 31.46% |
| 2007 Q2 | 195.6 Million USD | 0.66% |
| 2006 FY | 190.53 Million USD | 59.59% |
| 2006 Q4 | 190.53 Million USD | 0.0% |
| 2005 Q4 | 119.39 Million USD | 0.0% |
| 2005 FY | 119.39 Million USD | 0.0% |
| 2003 FY | 62.53 Million USD | 93.94% |
| 2002 FY | 32.24 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 22.044% |
| Addus HomeCare Corporation | 1.02 Billion USD | -307.793% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -1856.217% |
| Amedisys, Inc. | 2.06 Billion USD | -102.777% |
| American Oncology Network, Inc. | 374.45 Million USD | -1015.638% |
| Astrana Health, Inc. | 933.36 Million USD | -347.58% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | -155.17% |
| IMAC Holdings, Inc. | 1.14 Million USD | -365031.686% |
| biote Corp. | 155.29 Million USD | -2590.068% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -6723.732% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | -514.962% |
| COMPASS Pathways plc | 275.98 Million USD | -1413.673% |
| DocGo Inc. | 490.45 Million USD | -751.774% |
| Healthcare Services Group, Inc. | 803.18 Million USD | -420.124% |
| InnovAge Holding Corp. | 547.66 Million USD | -662.797% |
| Assure Holdings Corp. | 7.51 Million USD | -55496.766% |
| The Joint Corp. | 87.15 Million USD | -4693.459% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | -87.065% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -52443.621% |
| ModivCare Inc. | 1.76 Billion USD | -136.383% |
| NewGenIvf Group Limited | 1.64 Million USD | -253474.654% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -11646.859% |
| Option Care Health, Inc. | 3.32 Billion USD | -25.514% |
| P3 Health Partners Inc. | 860.96 Million USD | -385.215% |
| P3 Health Partners Inc. | 860.96 Million USD | -385.215% |
| The Pennant Group, Inc. | 539.69 Million USD | -674.062% |
| Surgery Partners, Inc. | 7.01 Billion USD | 40.483% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -84752.75% |
| Talkspace, Inc. | 142.22 Million USD | -2837.359% |
| Talkspace, Inc. | 142.22 Million USD | -2837.359% |
| The Oncology Institute, Inc. | 219.41 Million USD | -1803.919% |
| The Oncology Institute, Inc. | 219.41 Million USD | -1803.919% |